Showing results (1-10 of 10) with videos related to
Sort By:
Pageof 1
Journal of Bacteriology|December 15, 2005
Role of the novel OprD family of porins in nutrient uptake in Pseudomonas aeruginosaSandeep Tamber, Martina M Ochs, Robert E W HancockThe Journal of Biological Chemistry|February 8, 2011
Structure-guided antigen engineering yields pneumolysin mutants suitable for vaccination against pneumococcal diseaseEliud O Oloo, Jeremy A Yethon, Martina M Ochs, et al.Human Vaccines & Immunotherapeutics|April 28, 2015
Passive protection of mice against Streptococcus pneumoniae challenge by naturally occurring and vaccine-induced human anti-PhtD antibodiesRoger H Brookes, Marin Ming, Kimberley Williams, et al.Microbial Pathogenesis|November 17, 2007
Vaccine-induced human antibodies to PspA augment complement C3 deposition on Streptococcus pneumoniaeMartina M Ochs, William Bartlett, David E Briles, et al.Infection and Immunity|September 24, 2004
Lipoprotein PsaA in virulence of Streptococcus pneumoniae: surface accessibility and role in protection from superoxideJason W Johnston, Lisa E Myers, Martina M Ochs, et al.The Pediatric Infectious Disease Journal|May 23, 2013
Elevated inflammatory markers combined with positive pneumococcal urinary antigen are a good predictor of pneumococcal community-acquired pneumonia in childrenAnnick Galetto-Lacour, Gabriel Alcoba, Klara M Posfay-Barbe, et al.Journal of Immunology (Baltimore, Md. : 1950)|February 3, 2016
PcpA Promotes Higher Levels of Infection and Modulates Recruitment of Myeloid-Derived Suppressor Cells during Pneumococcal PneumoniaMelissa M Walker, Lea Novak, Rebecca Widener, et al.Human Vaccines & Immunotherapeutics|July 9, 2016
A bivalent pneumococcal histidine triad protein D-choline-binding protein A vaccine elicits functional antibodies that passively protect mice from Streptococcus pneumoniae challengeMartina M Ochs, Kimberley Williams, Anthony Sheung, et al.Plos One|March 7, 2018
Immunodominance in T cell responses elicited against different domains of detoxified pneumolysin PlyD1Els van Westen, Martien C M Poelen, Germie P J M van den Dobbelsteen, et al.Infection and Immunity|April 5, 2012
Neutralizing antibodies elicited by a novel detoxified pneumolysin derivative, PlyD1, provide protection against both pneumococcal infection and lung injuryDanielle Salha, Jason Szeto, Lisa Myers, et al.Pageof 1